Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy
Abstract Background Redirecting pre-existing virus-specific Intermediate cytotoxic CD8+ T lymphocytes (CTLs) to tumors by simulating a viral infection of the tumor cells has great potential for cancer immunotherapy.However, this strategy is limited by lack of amenable method for viral antigen delivery into the cytosol of target tumors.Here, we addr